Judgment of the Court of First Instance of 26 November 2002 in Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/00, T-137/00 and T-141/00: Artegodan GmbH and Others v Commission of the European Communities (Medicinal products for human use — Community arbitration procedures — Withdrawal of marketing authorisations — Competence — Criteria for withdrawal — Anorectics: amfepramone, clobenzorex, fenproporex, norpseudoephedrine, phentermine — Directives 65/65/EEC and 75/319/EEC)
Date: 2003-01-25
Institutions: Court of First Instance
Subjects: EU Member State, European Commission, action for annulment (EU), dangerous substance, market approval, medicinal product, pharmaceutical industry, withdrawal from the market

25.1.2003

EN

Official Journal of the European Communities

C 19/29

1. Dismisses the applications;

2. Orders the applicants to pay their own costs together with those

of the Commission.

( 1) OJ C 79 of 18.3.2000.

JUDGMENT OF THE COURT OF FIRST INSTANCE

of 26 November 2002

in Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00,
T-132/00, T-137/00 and T-141/00: Artegodan GmbH and
Others v Commission of the European Communities (1)

(Medicinal products for human use — Community arbi-
tration procedures — Withdrawal of marketing authoris-
ations — Competence — Criteria for withdrawal — Anorect-
ics: amfepramone, clobenzorex, fenproporex, norpseudoephe-
drine, phentermine — Directives 65/65/EEC and 75/319/
EEC)

(2003/C 19/53)

applicant in Case T-132/00, Cambridge Healthcare Supplies
Ltd, established in Norfolk (United Kingdom), represented by
D. Vaughan, K. Bacon, barristers, and S. Davis, solicitor, with
an address for service in Luxembourg, applicant in Case T-137/
00, Laboratoires pharmaceutiques Trenker SA, established in
Brussels, represented by L. Defalque and X. Leurquin, lawyers,
with an address for service in Luxembourg, applicant in Case
the European Communities
T-141/00, v Commission of
(Agents: H. Støvlbæk, R. Wainwright and B. Wägenbaur):
Application for annulment of the Commission decisions of
9 March 2000 concerning the withdrawal of marketing
authorisations of medicinal products for human use containing
respectively ‘amfepramone’ (C(2000) 453), as regards Cases
T-74/00, T-76/00 and T-141/00, inter alia‘norpseudoephedri-
ne’, ‘clobenzorex’ and ‘fenproporex’ (C(2000) 608), as regards
Cases T-83/00 to T-85/00, and ‘phentermine’ (C(2000) 452),
as regards Cases T-132/00 and T-137/00, the Court of First
Instance (Second Chamber, Extended Composition), composed
of: R.M. Moura Ramos, President, V. Tiili, J. Pirrung, P. Men-
gozzi and A.W.H. Meij, Judges; D. Christensen, Administrator,
for the Registrar, has given a judgment on 26 November 2002,
in which it:

1. Annuls the Commission Decisions of 9 March 2000 (C(2000)
452, C(2000) 453 and C(2000) 608) in so far as they relate
to the medicinal products marketed by the applicants;

2. Orders the Commission to pay all the costs, including those

incurred in the interlocutory proceedings.

(Language of the case: German, English and French)

(1) OJ C 149 of 27.5.2000, C 163 of 10.6.2000, C 192 of 8.7.2000

and C 233 of 12.8.2000.

In Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/
00, T-137/00 and T- 141/00, Artegodan GmbH, established
in Lüchow (Germany), represented by U. Doepner,
lawyer,
with an address for service in Luxembourg, applicant in Case
T-74/00, Bruno Farmaceutici SpA, established in Rome (Italy),
Essential Nutrition Ltd,
established in Brough (United
Kingdom), Hoechst Marion Roussel Ltd, established in Denham
(United Kingdom), Hoechst Marion Roussel SA, established in
Brussels (Belgium), Marion Merell SA, established in Puteaux
(France), Marion Merell SA, established in Barcelona (Spain),
Sanova Pharma GmbH, established in Vienna (Austria),
Temmler Pharma GmbH & Co. KG, established in Marburg
(Germany), represented by B. Sträter and M. Ambrosius,
lawyers, with an address for service in Luxembourg, applicants
in Case T-76/00, Schuck GmbH, established in Schwaig
(Germany), represented by B. Sträter and M. Ambrosius,
lawyers, with an address for service in Luxembourg, applicant
in Case T-83/00, Laboratórios Roussel Lda, established in Mem
Martins (Portugal), represented by B. Sträter and M. Ambrosius,
lawyers, with an address for service in Luxembourg, applicant
in Cases T-84/00 and T-85/00, Laboratoires Roussel Diamant
SARL, established in Puteaux (France), represented by B. Sträter
and M. Ambrosius, lawyers, with an address for service in
Luxembourg, applicant in Case T-84/00, Roussel Iberica SA,
established in Barcelona (Spain), represented by B. Sträter
and M. Ambrosius, lawyers, with an address for service in
Luxembourg, applicant in Case T-85/00, Gerot Pharmazeutika
GmbH, established in Vienna (Austria), represented by K. Grig-
lawyer, with an address for service in Luxembourg,
kar,

JUDGMENT OF THE COURT OF FIRST INSTANCE

of 22 October 2002

in Joined Cases T-178/00 and T-341/00, Jan Pflugradt v
European Central Bank (1)

(Staff of the European Central Bank — Amendment of
employment contract — Performance appraisal)

(2003/C 19/54)

(Language of the case: German)

In Joined Cases T-178/00 and T-341/00, Jan Pflugradt, residing
in Frankfurt am Main (Germany), represented in Case T-178/
00 by N. Pflüger, lawyer, and in Case T-341/00 by N. Pflüger,
R. Steiner and S. Mittländer, lawyers, with an address for
service in Luxembourg, v European Central Bank (Agents: in